Business Context and Reporting Period
This Form 6-K filing by Gold Fields Limited covers the month of March 2009. The report discloses a material transaction involving the grant of equity-based compensation to directors in compliance with JSE Listings Requirements.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the terms of a share-based compensation plan.
Material Changes and Transactions
On March 2, 2009, Gold Fields granted Share Appreciation Rights (SARS) and Performance Vesting Restricted Shares (PVRS) to directors, which were accepted on March 30, 2009.
- Share Appreciation Rights (SARS): Granted at a fixed strike price of R109.66. These vest after three years with a three-year exercise window. Settlement may be in cash or shares at the company's discretion.
- Performance Vesting Restricted Shares (PVRS): Granted at a zero strike price. Vesting is contingent on meeting performance criteria over a three-year period, primarily based on expected gold production. Awards may increase by up to 300% based on peer group performance.
Specific grants included:
- MD Fleischer: 20,400 SARS and 23,330 PVRS.
- PA Schmidt: 14,390 SARS and 18,750 PVRS.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, management commentary on market outlook, or specific risk factors. The primary contingency noted is the performance-based nature of the PVRS, which requires the company to meet specific gold production targets over the next three years for full settlement.
Investor Verification Checklist
- Verify the impact of the R109.66 SARS strike price relative to the current market price of Gold Fields shares.
- Confirm the specific gold production targets set for the PVRS performance criteria.
- Review the company's cash flow position to assess the ability to settle SARS in cash if the company elects that option.
- Check subsequent filings for the actual vesting status of these awards in 2012.